DS-5565
Phase 3Completed 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Diabetic Peripheral Neuropathic Pain
Conditions
Diabetic Peripheral Neuropathic Pain, Post-herpetic Neuralgia
Trial Timeline
Dec 1, 2015 → Mar 1, 2017
NCT ID
NCT02607280About DS-5565
DS-5565 is a phase 3 stage product being developed by Daiichi Sankyo for Diabetic Peripheral Neuropathic Pain. The current trial status is completed. This product is registered under clinical trial identifier NCT02607280. Target conditions include Diabetic Peripheral Neuropathic Pain, Post-herpetic Neuralgia.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02607280 | Phase 3 | Completed |
| NCT02234583 | Phase 3 | Completed |
Competing Products
20 competing products in Diabetic Peripheral Neuropathic Pain